VIVOS THERAPEUTICS INC (VVOS) Stock Income Statement
NASDAQ:VVOS - Nasdaq - US92859E2072 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.03M | 13.80M | 16.02M | 16.89M | 13.07M | |||
| Cost Of Goods | 6.01M | 5.53M | 6.01M | 4.28M | 2.65M | |||
| Gross Profit | 9.02M | 8.27M | 10.02M | 12.60M | 10.41M | |||
| Operating Expenses | 20.19M | 25.57M | 35.05M | 32.08M | 22.46M | |||
| Selling, General, and Administrative Expenses | 19.61M | 24.95M | 34.38M | 31.34M | 18.40M | |||
| Operating Income | -11.17M | -17.30M | -25.03M | -19.47M | -12.04M | |||
| Interest Income/Expense | N/A | N/A | 0.00 | 100.00K | -20.00K | |||
| Other Income/Expense | 35.00K | 3.71M | -100.00K | -10.00K | N/A | |||
| Non Recurring Items | N/A | 0.00 | 1.29M | -910.00K | 0.00 | |||
| Income Before Taxes | -11.14M | -13.58M | -23.85M | -20.29M | -12.06M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -11.14M | -13.58M | -23.85M | -20.29M | -12.06M | |||
| EBITDA | -10.59M | -16.68M | -24.36M | -18.74M | -11.32M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.22 | -11.14 | -25.92 | -23.89 | -16.52 | |||
| Non GAAP EPS | -2.91 | -10.92 | -20.08 | -9.14 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 60.00% | 59.93% | 62.55% | 74.60% | 79.65% | |||
| Profit Margin | -74.09% | -98.42% | -148.88% | -120.13% | -92.27% | |||
| Operating Profit Margin | -74.32% | -125.32% | -156.24% | -115.28% | -92.12% | |||
All data in USD